The estimated Net Worth of Gayle E Wilson is at least $10.4 Million dollars as of 5 May 2020. Gayle Wilson owns over 2,270 units of Gilead Sciences stock worth over $10,445,469 and over the last 21 years Gayle sold GILD stock worth over $0.
Gayle has made over 11 trades of the Gilead Sciences stock since 2004, according to the Form 4 filled with the SEC. Most recently Gayle exercised 2,270 units of GILD stock worth $183,734 on 5 May 2020.
The largest trade Gayle's ever made was exercising 104,800 units of Gilead Sciences stock on 19 November 2004 worth over $2,888,288. On average, Gayle trades about 6,092 units every 94 days since 2003. As of 5 May 2020 Gayle still owns at least 129,052 units of Gilead Sciences stock.
You can see the complete history of Gayle Wilson stock trades at the bottom of the page.
Gayle's mailing address filed with the SEC is GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404.
Over the last 22 years, insiders at Gilead Sciences have traded over $221,090,692 worth of Gilead Sciences stock and bought 30,121 units worth $1,879,767 . The most active insiders traders include John C Martin, Norbert W Bischofberger, and John F Milligan. On average, Gilead Sciences executives and independent directors trade stock every 9 days with the average trade being worth of $3,341,365. The most recent stock trade was executed by Deborah H Telman on 10 September 2024, trading 639 units of GILD stock currently worth $51,721.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead Sciences executives and other stock owners filed with the SEC include: